Value | Category | Cases | |
---|---|---|---|
1 | Oral administration | 40 |
66.7%
|
2 | Intravenous injection | 1 |
1.7%
|
3 | Topical Application | 0 |
0%
|
4 | Intramuscular injection | 19 |
31.7%
|
5 | Per Vagina | 0 |
0%
|
Sysmiss | 5928 |